BCAB (BioAtla, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
BioAtla, Inc. Common Stock (BCAB) is a publicly traded Healthcare sector company. As of May 21, 2026, BCAB trades at $3.62 with a market cap of $6.50M and a P/E ratio of -0.73. BCAB moved -3.36% today. Year to date, BCAB is -82.97%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.26 to $126.25. Rallies surfaces BCAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns BCAB stock?
Hedge funds tracked by Rallies that own BCAB include Scion Asset and Panagora Asset. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BioAtla, Inc. Common Stock.
BCAB Key Metrics
Key financial metrics for BCAB
Metric
Value
Price
$3.62
Market Cap
$6.50M
P/E Ratio
-0.73
EPS
$-4.97
Dividend Yield
0.00%
52-Week High
$126.25
52-Week Low
$3.26
Volume
0
Avg Volume
0
Revenue (TTM)
$2.00M
Net Income
$-50.62M
Gross Margin
0.00%
Top Hedge Funds Holding BCAB
Scion Asset holds 633.96K shares of BCAB, changed +0.00% as of Jun 30, 2024.
Panagora Asset holds 89.07K shares of BCAB, changed -20.02% as of Mar 31, 2024.
BCAB analyst coverage data. Average price target: $0.00.
Common questions about BCAB
Who owns BCAB stock?
Hedge funds tracked by Rallies that own BCAB include Scion Asset and Panagora Asset. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for BioAtla, Inc. Common Stock.
Does Rallies show 13F holders for BCAB?
Yes. Rallies tracks hedge fund and 13F ownership data for BCAB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BCAB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BCAB. It does not provide personalized investment advice.
